EXPE
74
2
SPG
53
-2
VRSK
35
-3
SHW
71
-2
UHS
58
4
SE
65
4
MPC
44
3
NUE
50
3
TRV
64
-3
FLS
46
-7
MRK
53
3
TJX
50
2
DTE
56
-7
HUM
30
3
EIX
69
-5
JPM
53
-2
TRIP
60
3
MCK
46
-3
PBI
62
2
PAYX
53
-4
EXPE
74
2
SPG
53
-2
VRSK
35
-3
SHW
71
-2
UHS
58
4
SE
65
4
MPC
44
3
NUE
50
3
TRV
64
-3
FLS
46
-7
MRK
53
3
TJX
50
2
DTE
56
-7
HUM
30
3
EIX
69
-5
JPM
53
-2
TRIP
60
3
MCK
46
-3
PBI
62
2
PAYX
53
-4
Financhill
Back

Ocular Therapeutix Quote, Financials, Valuation and Earnings

The Next Tech Giant in Your Pocket?

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
54

OCUL
Ocular Therapeutix

Last Price:
9.05
Seasonality Move:
1.23%

7 Day Trial

ALL ACCESS PASS

$ 7

Hedge fund manager warns about the market ahead

Free book prepares you for the coming uncertainty in the stock market

Ocular Therapeutix Price Quote

$9.05
-0.01 (-0.11%)
(Updated: September 19, 2024 at 6:55 PM ET)

Ocular Therapeutix Key Stats

Buy
54
Ocular Therapeutix (OCUL) is a Buy
Day range:
$8.63 - $9.14
52-week range:
$2.00 - $11.31
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
17.54
P/B ratio:
3.74%
Volume:
1.2M
Avg. volume:
891.2K
1-year change:
172.89%
Market cap:
$1.4B
Revenue:
$58.4M
EPS:
$-1.35

How Much Does Ocular Therapeutix Make?

Is Ocular Therapeutix Growing As A Company?

  • What Is Ocular Therapeutix's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.08%
  • What Is Ocular Therapeutix's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Ocular Therapeutix Stock Price Performance

What Is Ocular Therapeutix 52-Week High & Low?

Ocular Therapeutix Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Ocular Therapeutix?

  • How Much Debt Does Ocular Therapeutix Have?
    Total long term debt quarterly is $67.1M
  • How Much Cash Does Ocular Therapeutix Have?
    Cash and short term investments quarterly total is $459.7M
  • What Is Ocular Therapeutix’s Book Value Per Share?
    Book value per share is 2.43

Is Ocular Therapeutix Cash Flow Positive?

  • What Is OCUL Cash Flow From Operations?
    Cash flow from operations (TTM) is -$88.9M
  • What Is Ocular Therapeutix’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $483.5M
  • What Is Ocular Therapeutix’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$1.7M

Ocular Therapeutix Return On Invested Capital

  • Is Management Doing A Good Job?
    OCUL return on invested capital is -56.45%
  • What Is Ocular Therapeutix Return On Assets?
    ROA measures how assets are converting to revenues and is -43.43%
  • What Is OCUL Return On Equity?
    ROE is a measure of profitability and is -77.93%

Ocular Therapeutix Earnings Date & Stock Price

Ocular Therapeutix Competitors

  • Who Are Ocular Therapeutix's Competitors?
    Below is a list of companies who compete with Ocular Therapeutix or are related in some way:
    • Aptevo Therapeutics Inc (APVO)
    • Lyell Immunopharma Inc (LYEL)
    • Marinus Pharmaceuticals Inc (MRNS)
    • NovaBay Pharmaceuticals Inc (NBY)
    • Regeneron Pharmaceuticals Inc (REGN)

Ocular Therapeutix Dividend Yield

Ocular Therapeutix Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -21.88%
Revenue: 8.26% 3.75%

Analyst Recommendations

Buy Recommendations: 5
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 14.88
Upside from Last Price: 64.18%

Major Shareholders

  • How many OCUL shares are owned by institutional investors?
    178.7M OCUL shares are owned by institutional investors
  • How many OCUL shares are owned by insiders?
    4.4M OCUL shares are owned by insiders